	Zinsaufwendungen Für Schuld		Datum
Acadia Pharmaceuticals	USD 0	4.12M	2024-09
Agios Pharmaceuticals	USD 1.39B	85.53M	2025-09
Alnylam Pharmaceuticals	USD 129.34M	84.94M	2025-12
Amgen	USD 653M	32M	2025-12
Bayer	EUR 762M	267M	2025-09
Biogen	USD 72.6M	12.6M	2025-06
BioMarin Pharmaceutical	USD 2.78M	199K	2025-12
Gilead Sciences	USD 255M	1000K	2025-12
Incyte	USD 582K	10K	2025-12
Insmed	USD 20.6M	217K	2025-12
Ionis Pharmaceuticals	USD 18M	0	2025-12
Moderna	USD 12.14B	12.13B	2025-09
Neurocrine Biosciences	USD 1.1M	0	2024-03
PTC Therapeutics	USD 50.58M	2.59B	2025-12
Puma Biotechnology	USD 3.37M	11K	2024-06
Regeneron Pharmaceuticals	USD 12.2M	7.1M	2025-12
Roche Holding	CHF 304M	7.5M	2025-06
Sangamo BioSciences	97.56M	11.39M	2025-06
Sanofi	EUR -25M	99.78M	2025-12
Sarepta Therapeutics	USD 7.56M	2.33M	2025-09
Ultragenyx Pharmaceutical	USD 19M	4.85M	2025-12
United Therapeutics	USD 3.1M	100K	2025-12
Vertex Pharmaceuticals	USD 3.3M	0	2025-12

BioMarin Pharmaceutical Zinsaufwendungen Für Schuld - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2026.